Orphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company Soaring
15 Febbraio 2024 - 7:15PM
AllPennyStocks.com
Orphan drug designation, or ODD, is valuable on both a
humanitarian and a profitability basis. And this company is seeing
shares rally following news that it was granted the designation for
the...
To read the full story on AllPennyStocks.com, click
here.
Grafico Azioni Cardiol Therapeutics (NASDAQ:CRDL)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Cardiol Therapeutics (NASDAQ:CRDL)
Storico
Da Mag 2023 a Mag 2024
